Shopping Cart 0
Cart Subtotal
USD 0

Exalenz Bioscience Ltd (EXEN)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Exalenz Bioscience Ltd (EXEN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flagship product, BreathID Hp is a urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults. The BreathID Hp is US Food and Drug Administration (FDA) approved and CE-approved in Europe. The company offers products for detection of gastric adenocarcinoma, peptic ulcer disease and mucosa associated lymphoid tissue lymphoma. It works in collaboration with various clinical and industrial partners in Europe, Asia, the US and Israel. Exalenz is headquartered in Modiin, Israel.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Exalenz Bioscience Ltd-Key Facts 5

Exalenz Bioscience Ltd-Key Employees 6

Exalenz Bioscience Ltd-Key Employee Biographies 7

Exalenz Bioscience Ltd-Major Products and Services 8

Exalenz Bioscience Ltd-Medical Equipment Pipeline Products Data 9

Exalenz Bioscience Ltd Pipeline Products by Equipment Type 9

Exalenz Bioscience Ltd Pipeline Products by Development Stage 10

Exalenz Bioscience Ltd-History 12

Exalenz Bioscience Ltd-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Exalenz Bioscience Ltd-Business Description 14

Exalenz Bioscience Ltd-SWOT Analysis 15

SWOT Analysis-Overview 15

Exalenz Bioscience Ltd-Strengths 15

Exalenz Bioscience Ltd-Weaknesses 16

Exalenz Bioscience Ltd-Opportunities 17

Exalenz Bioscience Ltd-Threats 18

Exalenz Bioscience Ltd-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 26

Exalenz Bioscience Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017 27

Exalenz Bioscience Ltd, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Mar 14, 2016: Exalenz Biosciences Announces Collaboration with ALF Study Group to use BreathID to Monitor Patients with Acute Liver Failure 29

Section 6-Appendix 30

Methodology 30

Ratio Definitions 30

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Exalenz Bioscience Ltd Pipeline Products by Equipment Type 9

Exalenz Bioscience Ltd Pipeline Products by Development Stage 10

Exalenz Bioscience Ltd, Performance Chart (2012-2016) 23

Exalenz Bioscience Ltd, Ratio Charts 25

Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 26

Exalenz Bioscience Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 27


List Of Table

List of Tables

Exalenz Bioscience Ltd, Key Facts 5

Exalenz Bioscience Ltd, Key Employees 6

Exalenz Bioscience Ltd, Key Employee Biographies 7

Exalenz Bioscience Ltd, Major Products and Services 8

Exalenz Bioscience Ltd Pipeline Products by Equipment Type 9

Exalenz Bioscience Ltd Number of Pipeline Products by Development Stage 10

Exalenz Bioscience Ltd Pipeline Products Summary by Development Stage 11

Exalenz Bioscience Ltd, History 12

Exalenz Bioscience Ltd, Subsidiaries 13

Exalenz Bioscience Ltd, Key Competitors 19

Exalenz Bioscience Ltd, Ratios based on current share price 20

Exalenz Bioscience Ltd, Annual Ratios 21

Exalenz Bioscience Ltd, Annual Ratios (Cont...1) 22

Exalenz Bioscience Ltd, Interim Ratios 24

Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 26

Exalenz Bioscience Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017 27

Exalenz Bioscience Ltd, Recent Deals Summary 28

Currency Codes 30

Capital Market Ratios 30

Equity Ratios 31

Profitability Ratios 31

Cost Ratios 32

Liquidity Ratios 32

Leverage Ratios 33

Efficiency Ratios 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Wagner Analysen Technik GmbH Serim Research Corporation Meridian Bioscience Inc MedMira Inc Kibion AB